Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study).
Jiang W, Avdic S, Lee KH, Street J, Castellano-González G, Simms R, Clancy LE, Blennerhassett R, Patrick E, Chan AS, McGuire HM, Myers N, Gloss BS, Gabriel M, Bateman CM, Micklethwaite K, Gottlieb DJ, Blyth E. Jiang W, et al. Among authors: micklethwaite k. Leukemia. 2023 Nov;37(11):2330-2333. doi: 10.1038/s41375-023-02033-5. Epub 2023 Sep 15. Leukemia. 2023. PMID: 37714926 No abstract available.
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
Micklethwaite K, Hansen A, Foster A, Snape E, Antonenas V, Sartor M, Shaw P, Bradstock K, Gottlieb D. Micklethwaite K, et al. Biol Blood Marrow Transplant. 2007 Jun;13(6):707-14. doi: 10.1016/j.bbmt.2007.02.004. Epub 2007 Apr 6. Biol Blood Marrow Transplant. 2007. PMID: 17531781 Free article. Clinical Trial.
Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.
Micklethwaite KP, Clancy L, Sandher U, Hansen AM, Blyth E, Antonenas V, Sartor MM, Bradstock KF, Gottlieb DJ. Micklethwaite KP, et al. Blood. 2008 Nov 15;112(10):3974-81. doi: 10.1182/blood-2008-06-161695. Epub 2008 Sep 3. Blood. 2008. PMID: 18768783 Free article. Clinical Trial.
Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Clancy LE, Blyth E, Simms RM, Micklethwaite KP, Ma CK, Burgess JS, Antonenas V, Shaw PJ, Gottlieb DJ. Clancy LE, et al. Among authors: micklethwaite kp. Biol Blood Marrow Transplant. 2013 May;19(5):725-34. doi: 10.1016/j.bbmt.2013.01.021. Epub 2013 Feb 1. Biol Blood Marrow Transplant. 2013. PMID: 23380344 Free article.
Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.
Bradstock KF, Bilmon I, Kwan J, Micklethwaite K, Blyth E, Deren S, Bayley A, Gebski V, Gottlieb D. Bradstock KF, et al. Among authors: micklethwaite k. Biol Blood Marrow Transplant. 2015 May;21(5):941-4. doi: 10.1016/j.bbmt.2015.01.020. Epub 2015 Jan 27. Biol Blood Marrow Transplant. 2015. PMID: 25636379 Free article. Clinical Trial.
46 results